PAUL SIMPSON: Open Payments
NPI 1043530942 · THREE RIVERS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$117 in 6 payments from 6 companies in 2025. Trend: 2023 $412 · 2024 $833 · 2025 $117
Food & beverage: $117
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: ELIQUIS, Ozempic, JARDIANCE, OTEZLA, GARDASIL 9, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
